Comprehensive Healthcare Systems Inc
CHS
Water Ways Technologies Inc
WWT
TVI Pacific Inc
TVI
Magna Terra Minerals Inc
MTT
Marksmen Energy Inc
MAH
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 49.95%18.35M | 23.72%18.05M | 11.43%15.56M | -13.31%55.03M | 9.69%14.23M | -23.73%12.24M | -14.63%14.59M | -19.57%13.97M | 65.10%63.47M | -7.64%12.97M |
Operating revenue | 49.95%18.35M | 23.72%18.05M | 11.43%15.56M | -13.31%55.03M | 9.69%14.23M | -23.73%12.24M | -14.63%14.59M | -19.57%13.97M | 65.10%63.47M | -7.64%12.97M |
Cost of revenue | 33.76%8.84M | 2.78%8.29M | 5.21%7.28M | -3.85%28.45M | -6.39%6.86M | -4.00%6.61M | 3.99%8.06M | -9.26%6.92M | 76.87%29.59M | 46.46%7.33M |
Gross profit | 68.97%9.51M | 49.60%9.76M | 17.53%8.29M | -21.57%26.57M | 30.57%7.37M | -38.57%5.63M | -30.09%6.53M | -27.63%7.05M | 56.03%33.88M | -37.58%5.64M |
Operating expense | 25.16%1.86M | -5.29%1.59M | 31.70%1.63M | 28.03%7.84M | 69.14%3.44M | 15.41%1.48M | 31.47%1.68M | -18.94%1.24M | -24.97%6.12M | -23.53%2.03M |
Selling and administrative expenses | 45.03%1.14M | -5.94%1.19M | 26.44%1.25M | 47.02%6.19M | 161.38%3.15M | -18.88%787.66K | 53.17%1.26M | -18.15%989.33K | -45.58%4.21M | -64.36%1.2M |
-General and administrative expense | 45.03%1.14M | -5.94%1.19M | 26.44%1.25M | 47.02%6.19M | 161.38%3.15M | -18.88%787.66K | 53.17%1.26M | -18.15%989.33K | -45.58%4.21M | -64.36%1.2M |
Research and development costs | -23.44%416.36K | -21.54%284.6K | 217.04%257.48K | -17.47%1.19M | -73.89%203.77K | 245.83%543.83K | 12.48%362.73K | -55.75%81.21K | 87.66%1.44M | 438.64%780.49K |
Depreciation amortization depletion | -2.31%102.08K | 225.31%98.2K | -32.47%94.86K | 3.33%335K | 398.19%59.85K | -3.21%104.49K | -70.41%30.19K | 37.45%140.47K | -5.20%324.2K | -78.72%12.01K |
-Depreciation and amortization | -2.31%102.08K | 225.31%98.2K | -32.47%94.86K | 3.33%335K | 398.19%59.85K | -3.21%104.49K | -70.41%30.19K | 37.45%140.47K | -5.20%324.2K | -78.72%12.01K |
Other operating expenses | 321.01%194.36K | -14.59%22.87K | 0.86%27.22K | -13.97%126.77K | -25.21%26.84K | -3.88%46.17K | -12.44%26.78K | -17.84%26.98K | 121.59%147.35K | 103.89%35.89K |
Operating profit | 84.64%7.65M | 68.63%8.17M | 14.51%6.66M | -32.51%18.73M | 8.85%3.93M | -47.37%4.14M | -39.86%4.85M | -29.25%5.81M | 104.80%27.76M | -43.43%3.61M |
Net non-operating interest income (expenses) | 135.64%563.41K | 188.09%608.21K | 240.99%565.91K | 280.57%880.48K | -12.56%264.3K | 467.67%239.1K | 361.24%211.12K | 574.43%165.96K | 771.60%231.36K | 67.27%302.28K |
Non-operating interest income | 94.43%629.07K | 124.00%684.18K | 144.42%642.02K | 114.89%1.24M | -14.85%346.02K | 189.79%323.55K | 173.30%305.44K | 275.03%262.67K | 27.09%575.97K | 55.11%406.34K |
Non-operating interest expense | -22.25%65.66K | -19.46%75.97K | -21.30%76.11K | 3.65%357.2K | -21.48%81.72K | 21.46%84.45K | 42.93%94.32K | -7.91%96.71K | -29.33%344.61K | 28.07%104.06K |
Other net income (expenses) | -1,528.58%-256.62K | -33.08%83.57K | 195.42%39.92K | 86.56%-178.6K | 53.68%-245.89K | 98.27%-15.76K | -28.68%124.89K | 77.74%-41.84K | -10,455.27%-1.33M | -158.54%-530.81K |
Gain on sale of security | -1,709.45%-256.62K | -33.08%83.57K | 193.50%39.92K | 90.12%-116.81K | 42.96%-184.81K | 98.49%-14.18K | -12.95%124.89K | 33.43%-42.7K | -566.20%-1.18M | -1,359.32%-324.01K |
Special income (charges) | --0 | --0 | --0 | -3,540.99%-60.36K | -1.41%-59.64K | -105.45%-1.58K | --0 | --857 | 100.79%1.75K | -12,024.74%-58.81K |
-Less:Impairment of capital assets | ---- | ---- | ---- | --59.64K | ---- | ---- | ---- | ---- | --0 | ---- |
-Gain on sale of property,plant,equipment | --0 | --0 | --0 | -140.82%-716 | 100.00%2 | -105.45%-1.58K | --0 | --857 | 101.16%1.75K | -12,024.74%-58.81K |
Other non-operating income (expenses) | ---- | ---- | ---- | 99.03%-1.44K | ---- | ---- | ---- | ---- | -656.47%-147.99K | ---- |
Income before tax | 82.22%7.96M | 71.05%8.86M | 22.32%7.26M | -27.10%19.44M | 16.75%3.95M | -37.68%4.37M | -37.40%5.18M | -25.72%5.94M | 97.02%26.66M | -54.73%3.38M |
Income tax | 61.32%2.19M | 52.00%2.92M | 11.14%2.12M | -22.01%7.21M | -14.13%2.02M | -27.66%1.35M | -21.20%1.92M | -25.88%1.91M | 58.89%9.24M | -69.05%2.36M |
Earnings from equity interest net of tax | ||||||||||
Net income | 91.63%5.77M | 82.25%5.95M | 27.62%5.14M | -29.81%12.23M | 87.79%1.92M | -41.33%3.01M | -44.16%3.26M | -25.65%4.03M | 125.75%17.42M | 798.36%1.02M |
Net income continuous operations | 91.63%5.77M | 82.25%5.95M | 27.62%5.14M | -29.81%12.23M | 87.79%1.92M | -41.33%3.01M | -44.16%3.26M | -25.65%4.03M | 125.75%17.42M | 798.36%1.02M |
Noncontrolling interests | 175.70%2.72M | 152.38%3.05M | 82.23%2.5M | -26.36%4.67M | 30.67%1.1M | -43.24%988.06K | -33.50%1.21M | -29.29%1.37M | 97.69%6.34M | 26.86%842.75K |
Net income attributable to the company | 50.60%3.05M | 40.92%2.89M | -0.60%2.64M | -31.78%7.56M | 352.34%822.99K | -40.35%2.02M | -48.97%2.05M | -23.62%2.66M | 145.72%11.08M | 122.43%181.94K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 50.60%3.05M | 40.92%2.89M | -0.60%2.64M | -31.78%7.56M | 352.34%822.99K | -40.35%2.02M | -48.97%2.05M | -23.62%2.66M | 145.72%11.08M | 122.43%181.94K |
Diluted earnings per share | 50.57%0.0029 | 40.91%0.0028 | -0.63%0.0025 | 0.00%0.01 | 0 | -40.34%0.0019 | -48.96%0.002 | -74.52%0.0025 | 0.00%0.01 | 0 |
Basic earnings per share | 50.57%0.0029 | 40.91%0.0028 | -0.63%0.0025 | 0.00%0.01 | 0 | -40.34%0.0019 | -48.96%0.002 | -74.52%0.0025 | 0.00%0.01 | 0 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.